Ablation of Id2 in HSCs results in increased proliferation, suggesting that ID2 may function as a tumor suppressor; however, we did not monitor the Id2Δ/Δ mice in these experiments beyond 12–16 weeks, when hematopoietic malignancies might develop. This evidence concerns the gene ID2 and neoplasm.